A ONCE-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with ...

A phase 3 clinical trial reports that nerandomilast was associated with a smaller decline in forced vital capacity in ...

A 2024 nationwide survey of French ICUs reveals critical gaps in managing invasive candidiasis, including underutilization of ...

Presented at EuroPCR 2025, the 10-year results of the DANAMI-3-PRIMULTI trial show how complete revascularisation cuts ...

Discover a Phase 3 trial that evaluated stapokibart as an additional therapy for adults with moderate-to-severe seasonal ...

In people living with HIV, gut microbiome differences linked to antiretroviral therapy and weight gain are small compared to ...

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

A new review examines the effectiveness of surgical treatments for severe osteoarthritis, highlighting the dominance of total ...

Discover a study about an AI model named PLAN-B-DF that has been developed to improve the prediction of hepatocellular ...

Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to ...

New research from COMy 2025 reveals a high rate of infections among people with relapsed or refractory multiple myeloma ...

New research, from COMy 2025, has found that specific senescence-associated biomarkers are significantly correlated with ...